The use of phosphate binders was associated with a lower risk of incident dementia [18], and a higher serum fibroblast growth factor-23 (FGF23) level was cross-sectionally associated with lower cognitive function in patients with kidney failure [19]. Here, FGF23 is linked to kidney failure.